Topic description and stories

New technologies and strong academic-industry partnerships have the potential to change the face of therapeutic medicine.

Baby Opal and mother Jo

Baby born deaf can hear after breakthrough gene therapy

09 May 2024

A baby girl born deaf can hear unaided for the first time, after receiving gene therapy when she was 11 months old at Addenbrooke’s Hospital in...

Read more
Illustration of mRNA strand

Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

06 Dec 2023

Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body...

Read more
Digital generated image of different variants of virus cells against a black background.

New vaccine technology could protect from future viruses and variants

25 Sep 2023

Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in...

Read more

Could this monster help you overcome anxiety?

29 Jul 2022

In 2017, Ninja Theory, advised by Cambridge academic Professor Paul Fletcher, took the gaming world by storm with Hellblade, which accurately...

Read more
Web network graphic

Collaboration could enable cancer patients to get faster and more personalised treatment

29 Nov 2021

GE Healthcare, the University of Cambridge and Cambridge University Hospitals have agreed to collaborate on developing an application aiming to...

Read more
Graphical representation of COVID-19 and network analysis

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 Jun 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19...

Read more


Heal thyself

24 May 2021

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore...

Read more
Human cells with acute myelocytic leukemia, shown with an esterase stain at 400x

Scientists develop new class of cancer drug with potential to treat leukaemia

26 Apr 2021

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published...

Read more
Screening for glaucoma

Gene therapy technique shows potential for repairing damage caused by glaucoma and dementia

31 Mar 2021

Scientists at the University of Cambridge have shown in animal studies that gene therapy may help repair some of the damage caused in chronic...

Read more


Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable

22 Mar 2021

UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection...

Read more
Creative rendition of SARS-COV-2 virus particles

Remdesivir likely to be highly effective antiviral against SARS-CoV-2 for some patients

14 Dec 2020

The drug remdesivir is likely to be a highly effective antiviral against SARS-CoV-2, according to a new study by a team of UK scientists. Writing in...

Read more

Recruitment underway as Cambridgeshire NHS trusts join COVID-19 vaccine trial

11 Jun 2020

Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.

Read more